Trade Bristol-Myers Squibb Co - BMY CFD

Trading Conditions
Spread0.11
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02629 %
(-$5.00)

Trade size with leverage ~ $20,000.00

Short position overnight funding adjustment ~ $19,000.00


-0.02629%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.004068 %
($0.77)

Trade size with leverage ~ $20,000.00

Short position overnight funding adjustment ~ $19,000.00


0.004068%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin5%
Stock exchangeUnited States of America
Commission on trade0%
Key Stats
Prev. Close42.34
Open42.1
1-Year Change-32.11%
Day's Range41.6 - 42.75

Bristol-Myers Squibb Company profile

What is Bristol-Myers Squibb Co.?

The Bristol-Myers Squibb Company is an international biopharmaceutical company specialising in discovering, developing and delivering innovative biopharmaceutical products and medicines to patients who suffer from serious diseases. Bristol-Myers Squibb provides medicines to help people fight cancer, hepatitis B and C, cardiovascular disease, HIV and AIDS. The company supplies its products to retail and wholesale pharmacies, governmental entities, and hospitals throughout the world.
 

What’s the history behind the company?

1858 – The Squibb corporation is founded by Edward Robinson Squibb in New York.
 
1887 – The Clinton Pharmaceutical company i purchased by William McLaren Bristol and John Ripley Myers. Two years later they rename it as “Bristol, Myers and Company”, and later, following Myers death in 1899 as the “Bristol-Myers Corporation”.
 
1903 – Sal Hepatica, a laxative salt is developed and released marking the first product for the company.
 
1943 – Acquisition of Cheplin Biological Laboratories, Bristol laboratories in 1945 creating antibiotics, is met with competition from Squibbs.
 
1989 – Bristol-Myers merges with Squibb to form Bristol-Myers Squibb, creating one of the world’s largest pharmaceutical companies.
 
1998 – Development of Excedrin Migraine, one of the first migraine medications available without a prescription in the US.
 
2004 – Bristol-Myers Squibb pays $150 million in a settlement for accounting fraud, the company does not admit or deny guilt. In 2006, the company is hit again by charges and pays $2.1 million to the Federal Trade Commission.
 
2008 – The company undertakes a number of partnerships, including therapy for cardiovascular diseases with KAI pharmaceuticals, cancer therapies with Kosan, and two novel therapies for cancer with Exelixis. These collaborations continue into 2009 with more added.
 
2010 – Lamberto Andreotti took over as CEO of Bristol-Myers Squibb. By 2012, the company’s net sales reach $17.6 billion.
 
2015 – Dr. Giovanni Caforio becomes the head of the company.
 

About the company

Bristol-Myers Squibb operates worldwide with locations such as Asia, including China and Japan, Southeast Asia in Bangalore India, across Europe in Belgium, England, France, Ireland and Italy, and North America. This includes a number of research and development facilities, vital to the creation of new pharmaceutical products.
 
Across its facilities, the company employs approximately 23,700 people. To date, Dr. Giovanni Caforio is the Chairman and CEO of the company with Charles Bancroft as CFO.
 
The company has numerous awards and achievements, including 2018 Best-of-the-Best Corporations for Inclusion by National Business Inclusion Consortium, Fortune’s World’s Most Admired Companies, Dow Jones' 2017 North American Index of Leading Sustainable Companies, and Forbes America’s Best Employers for 2016.
 

Key Statistics

  • Revenue in 2017 – $20.78 billion
  • Net income in 2017 – $975 million
  • Total assets in 2017 – 33.55 billion
  • Total equity in 2017 – 11.85 billion

Major acquisitions

  • Adnexus Therapeutics – 2007
  • Kosan Biosciences – 2008
  • Medarex – 2009
  • ZymoGenetics – 2010
  • Amira Pharmaceuticals – 2011
  • Inhibitex Inc. – 2012
  • Amylin Pharmaceuticals and AstraZeneca – 2018
  • iPierian – 2014
  • Flexus Biosciences – 2015
  • Cardioxyl – 2015
  • Padlock Therapeutics – 2016
  • Cormorant Pharmaceuticals – 2016
  • IFM Therapeutics – 2017

Where is Bristol-Myers Squibb Co. traded?

Bristol-Myers Squibb is traded on the New York Stock Exchange (NYSE) under the ticker BMY. It is also a component of the S&P 100 and S&P 500. Trade the latest Bristol-Myers Squibb share price with Capital.com, explore the most up-to-date BMY charts, and delve into this pharmaceutical company.

Latest shares articles

Lloyds share price forecast: An attractive dividend stock?
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
13:36, 8 July 2024
Exterior of Infosys headquarters
Infosys shareholders: Who owns the most INFY stock?
Who are the major shareholders and decision-makers of Infosys?
07:12, 29 April 2024
Tesla logo atop of a Tesla Dealership illuminated at night.
Tesla shareholders: Who owns the most TSLA stock?
In this guide to Tesla’s ownership structure, we look at the biggest TSLA shareholders – both institutional and individual
08:00, 19 April 2024
US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co
The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.
14:43, 2 February 2024

Read our reviews to find out more about us

Read the feedback from our clients, whatever their experience level.

the simplicity and the pros of this app makes it amazing and a useful app

Hafsa

I have already tested many brokers and I can definitely say that Capital.com is the most professional trading tool.

PaCeKw

Capital.com is a good broker. I haven't had any problems with the trading platform but i qould advise that they add an option for either using lots or units.

Mr-phenom

I am in the first time but I look this website in YouTube there's a very good and safe platform for a traders Thinks for taking my opinion

MUHAMMAD JALIL MUHAMMAD ASGHAR

great UI, simple platform, low spreads, great coverage

Jihad Kattar

The videos are easy to follow, i get my profits and downs and understand the market now even more. This app is very well to understand. I would recommend this app to friends if they want to know.

Customer

Good and amazing app for trading and easy setups easy and smooth buy and sell amazing

QAISAR ALI

Excellent for people who would like to get and build all the experience needed to navigate to Stock Market.

Johnsy81

Overall my experience is very good with capital, the one best thing is they give you call support with most other broker apps don’t gives.

Ranjit

I have been usingCapital.comm platform for a year now. I did have some issues with using the platform in the earlier days but I received excellent support from Capital.com guiding me in the process of learning about the platform and put me on track. I am very happy with this platform and find it very easy to use for my trading needs. Capital.com also arranged a series of trading webinars last summer, which I attended and benefited from.

Dr Anjum Pervez

The best app for trade ever I tried to much trade app and this is the best

Moamen

Great website, easy to use and user friendly. Lot of markets to trade with. Good database of information and learning tutorials for beginner. Great customer support. I had some issues and they helped me solve them rapidly. One of the best broker, I recommend.

Nicolas Crampet

Trusted trading Platform Capital.com is the most trusted trading platform I ever experienced. Even without taking any demo,I have started funding and it’s going well. It is a very easy platform for the beginners and can have better trading experience by using this

JEYAKUMAR

great app, love the weekly and monthly insights, and review they send about my trading habits. spread for gold is usually 0.3 but at times fluctuates up to 0.9 this often makes it hard trading on the low time frames and not losing my position to spread even if my bias was correct, if the spread was better I'd give 5 star.

chris hoeben

Capital.com is the best broker of all time and I Should give it five stars but there is a small issue about execution of my orders through traddingview it is a bit slow. But the execution of orders directly from the capital.com App or Website is absolutely fast and apart from that everything is simple incredible.

IKOFO MOISE

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading